On 2026-03-25, Maze Therapeutics, Inc. (MAZE) announced earnings per share of $-0.65 for the fiscal quarter ending 2025-12-31, beating the average analyst estimate of $-0.73.
The next expected annoucement date for quarterly earnings is 2026-05-13, with an average estimated earnings per share of $-0.44 for the fiscal quarter ending 2026-03-31.
Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.
| Announcement Date | Fiscal Quarter End | Estimated EPS | Actual EPS |
|---|---|---|---|
| 2026-03-25 | 2025-12-31 | $-0.73 | $-0.65 |
| 2025-11-06 | 2025-09-30 | $-0.74 | $-0.66 |
| 2025-08-12 | 2025-06-30 | $-0.79 | $-0.77 |
| 2025-05-14 | 2025-03-31 | $-0.76 | $-1.15 |
| 2025-03-31 | 2024-12-31 | $-7.60 | $-18.32 |